StonvexLoading…
StonvexStonvexStonvexCore line items from BCYC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $72.59M | $35.27M | $26.98M | $14.46M |
Operating Income | $-247.06M | $-209.87M | $-189.95M | $-116.65M |
Net Income | $-218.96M | $-169.03M | $-180.66M | $-112.72M |
EPS (Diluted) | $-3.16 | $-2.90 | $-5.08 | $-3.80 |
Total Assets | $717.60M | $956.87M | $595.34M | $410.61M |
Total Liabilities | $107.62M | $163.81M | $224.41M | $139.83M |
Cash & Equivalents | $628.11M | $879.52M | $526.42M | $339.15M |
Free Cash Flow OCF − CapEx | $-252.03M | $-165.96M | $-63.56M | $-105.10M |
Shares Outstanding | 69.37M | 69.06M | 42.43M | 29.87M |